Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	PMS1 DNHD1 MYH2 MYH6 ABCF1 SETX ATRX RAD54L2 RFC5 ATP2B1 ATP2B2 ATP2B3 DDX11L8	2.02e-05	614	105	13	GO:0140657
GeneOntologyMolecularFunction	P-type calcium transporter activity	ATP2B1 ATP2B2 ATP2B3	2.26e-05	11	105	3	GO:0005388
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	PMS1 SETX ATRX RAD54L2 RFC5 DDX11L8	5.66e-05	127	105	6	GO:0008094
GeneOntologyMolecularFunction	methylated histone binding	ATRX DPF2 SETD5 SGF29 TAF1L	9.07e-05	86	105	5	GO:0035064
GeneOntologyMolecularFunction	methylation-dependent protein binding	ATRX DPF2 SETD5 SGF29 TAF1L	1.01e-04	88	105	5	GO:0140034
GeneOntologyMolecularFunction	calcium-dependent ATPase activity	MYH6 ATP2B2	1.63e-04	4	105	2	GO:0030899
GeneOntologyMolecularFunction	general transcription initiation factor activity	SNAPC5 GTF2E1 GTF3C1 TAF1L	4.54e-04	68	105	4	GO:0140223
GeneOntologyMolecularFunction	ATP hydrolysis activity	PMS1 ABCF1 ATRX RAD54L2 RFC5 ATP2B1 ATP2B2 ATP2B3 DDX11L8	5.33e-04	441	105	9	GO:0016887
GeneOntologyMolecularFunction	modification-dependent protein binding	ATRX DPF2 SETD5 HTATSF1 SGF29 TAF1L	7.73e-04	206	105	6	GO:0140030
GeneOntologyMolecularFunction	P-type transmembrane transporter activity	ATP2B1 ATP2B2 ATP2B3	8.89e-04	36	105	3	GO:0140358
GeneOntologyMolecularFunction	P-type ion transporter activity	ATP2B1 ATP2B2 ATP2B3	8.89e-04	36	105	3	GO:0015662
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	CACNA1F RYR1 ATP2B1 ATP2B2 ATP2B3	1.22e-03	151	105	5	GO:0015085
GeneOntologyMolecularFunction	calmodulin binding	MYH2 MYH6 RYR1 ATP2B1 ATP2B2 ATP2B3	1.36e-03	230	105	6	GO:0005516
GeneOntologyMolecularFunction	helicase activity	SETX ATRX RAD54L2 RFC5 DDX11L8	1.49e-03	158	105	5	GO:0004386
GeneOntologyMolecularFunction	RNA polymerase III general transcription initiation factor activity	SNAPC5 GTF3C1	2.06e-03	13	105	2	GO:0000995
GeneOntologyMolecularFunction	RNA polymerase II general transcription initiation factor activity	SNAPC5 GTF2E1 TAF1L	2.59e-03	52	105	3	GO:0016251
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	PMS1 SETX ATRX RAD54L2 RFC5 DDX11L8	2.63e-03	262	105	6	GO:0140097
GeneOntologyMolecularFunction	histone binding	ATRX NASP DPF2 SETD5 SGF29 TAF1L	2.78e-03	265	105	6	GO:0042393
GeneOntologyBiologicalProcess	nuclear mRNA surveillance of mRNA 3'-end processing	DIS3 ZCCHC7	2.57e-05	2	105	2	GO:0071031
GeneOntologyCellularComponent	nuclear protein-containing complex	PMS1 RANBP2 PNN KDM3B NPIPA1 DPF2 RFC5 CWC22 DIS3 CRNKL1 GTF2E1 BRD8 SETD5 HTATSF1 FIP1L1 BOD1L1 MPHOSPH10 ZCCHC7 TAF1L MVP DDX11L8	6.54e-06	1377	108	21	GO:0140513
GeneOntologyCellularComponent	axonemal dynein complex	DNHD1 DNAI4 DNAI7	2.84e-04	25	108	3	GO:0005858
GeneOntologyCellularComponent	sarcomere	MYH2 MYH6 RYR1 CRYAB HRC TNNT3 NBR1	3.14e-04	249	108	7	GO:0030017
GeneOntologyCellularComponent	desmosome	KLHL24 PNN CTNNA3	4.00e-04	28	108	3	GO:0030057
GeneOntologyCellularComponent	myofibril	MYH2 MYH6 RYR1 CRYAB HRC TNNT3 NBR1	5.45e-04	273	108	7	GO:0030016
GeneOntologyCellularComponent	nuclear body	SETX CENPT ATRX INCENP PNN SNAPC5 RAD54L2 CWC22 CRNKL1 SLTM ZFHX3 TREML1 NBR1	7.76e-04	903	108	13	GO:0016604
GeneOntologyCellularComponent	contractile muscle fiber	MYH2 MYH6 RYR1 CRYAB HRC TNNT3 NBR1	7.77e-04	290	108	7	GO:0043292
GeneOntologyCellularComponent	Ctf18 RFC-like complex	RFC5 DDX11L8	1.16e-03	10	108	2	GO:0031390
GeneOntologyCellularComponent	inner dynein arm	DNHD1 DNAI7	1.16e-03	10	108	2	GO:0036156
GeneOntologyCellularComponent	neuronal cell body membrane	KCNJ6 ATP2B1 ATP2B2	1.42e-03	43	108	3	GO:0032809
GeneOntologyCellularComponent	parallel fiber to Purkinje cell synapse	KCNJ6 ATP2B2 ATP2B3	1.42e-03	43	108	3	GO:0098688
GeneOntologyCellularComponent	chromatin	ZEB1 ATRX INCENP MYT1 KDM3B NASP IRF6 DPF2 IRX1 ZEB2 BRD8 SETD5 ZFHX3 TSHZ1 SGF29 TAF1L DDX11L8	1.50e-03	1480	108	17	GO:0000785
GeneOntologyCellularComponent	cell body membrane	KCNJ6 ATP2B1 ATP2B2	1.84e-03	47	108	3	GO:0044298
Domain	ATP_Ca_trans_C	ATP2B1 ATP2B2 ATP2B3	7.28e-07	4	107	3	IPR022141
Domain	ATP_Ca_trans_C	ATP2B1 ATP2B2 ATP2B3	7.28e-07	4	107	3	PF12424
Domain	P-type_ATPase_IIB	ATP2B1 ATP2B2 ATP2B3	7.28e-07	4	107	3	IPR006408
Domain	NPIP	NPIPA1 NPIPA5 NPIPA3	6.36e-05	14	107	3	IPR009443
Domain	-	ATP2B1 ATP2B2 ATP2B3	9.70e-05	16	107	3	1.20.1110.10
Domain	ATPase_P-typ_TM_dom	ATP2B1 ATP2B2 ATP2B3	9.70e-05	16	107	3	IPR023298
Domain	ATPase_P-typ_cation-transptr_C	ATP2B1 ATP2B2 ATP2B3	1.17e-04	17	107	3	IPR006068
Domain	Cation_ATPase_C	ATP2B1 ATP2B2 ATP2B3	1.17e-04	17	107	3	PF00689
Domain	Cation_ATPase_N	ATP2B1 ATP2B2 ATP2B3	1.40e-04	18	107	3	PF00690
Domain	Cation_ATPase_N	ATP2B1 ATP2B2 ATP2B3	1.40e-04	18	107	3	SM00831
Domain	ATPase_P-typ_cation-transptr_N	ATP2B1 ATP2B2 ATP2B3	1.66e-04	19	107	3	IPR004014
Domain	Di19_Zn_binding_dom	ZEB1 ZEB2	6.70e-04	7	107	2	IPR008598
Domain	zf-Di19	ZEB1 ZEB2	6.70e-04	7	107	2	PF05605
Domain	ATPase_P-typ_cyto_domN	ATP2B1 ATP2B2 ATP2B3	1.05e-03	35	107	3	IPR023299
Domain	HAD-like_dom	PITPNM2 ATP2B1 ATP2B2 ATP2B3	1.10e-03	79	107	4	IPR023214
Domain	P_typ_ATPase	ATP2B1 ATP2B2 ATP2B3	1.14e-03	36	107	3	IPR001757
Domain	ATPase_P-typ_P_site	ATP2B1 ATP2B2 ATP2B3	1.14e-03	36	107	3	IPR018303
Domain	ATPASE_E1_E2	ATP2B1 ATP2B2 ATP2B3	1.14e-03	36	107	3	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP2B1 ATP2B2 ATP2B3	1.23e-03	37	107	3	IPR008250
Domain	E1-E2_ATPase	ATP2B1 ATP2B2 ATP2B3	1.23e-03	37	107	3	PF00122
Domain	Hydrolase_3	ATP2B2 ATP2B3	1.42e-03	10	107	2	PF08282
Domain	Myosin_N	MYH2 MYH6	3.25e-03	15	107	2	PF02736
Domain	Myosin_N	MYH2 MYH6	3.25e-03	15	107	2	IPR004009
Domain	WD40	WDR7 WDR70 SEC31A CFAP43 WDHD1 DNAI4	4.46e-03	268	107	6	SM00320
Domain	Myosin_tail_1	MYH2 MYH6	4.69e-03	18	107	2	PF01576
Domain	Myosin_tail	MYH2 MYH6	4.69e-03	18	107	2	IPR002928
Domain	WD40_repeat	WDR7 WDR70 SEC31A CFAP43 WDHD1 DNAI4	4.79e-03	272	107	6	IPR001680
Domain	Myosin-like_IQ_dom	MYH2 MYH6	5.22e-03	19	107	2	IPR027401
Domain	-	MYH2 MYH6	5.22e-03	19	107	2	4.10.270.10
Domain	WD_REPEATS_1	WDR7 WDR70 SEC31A CFAP43 WDHD1 DNAI4	5.32e-03	278	107	6	PS00678
Domain	WD_REPEATS_2	WDR7 WDR70 SEC31A CFAP43 WDHD1 DNAI4	5.41e-03	279	107	6	PS50082
Domain	WD_REPEATS_REGION	WDR7 WDR70 SEC31A CFAP43 WDHD1 DNAI4	5.41e-03	279	107	6	PS50294
Pathway	REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	ATP2B1 ATP2B2 ATP2B3	3.73e-05	12	80	3	M27326
Pathway	REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	ATP2B1 ATP2B2 ATP2B3	6.12e-05	14	80	3	MM15052
Pathway	REACTOME_ION_HOMEOSTASIS	RYR1 ATP2B1 ATP2B2 ATP2B3	2.45e-04	54	80	4	M27460
Pathway	REACTOME_ION_HOMEOSTASIS	RYR1 ATP2B1 ATP2B2 ATP2B3	2.45e-04	54	80	4	MM15202
Pathway	REACTOME_MUSCLE_CONTRACTION	MYH6 RYR1 TNNT3 ATP2B1 ATP2B2 ATP2B3	3.45e-04	165	80	6	MM15026
Pathway	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	ATP2B1 ATP2B2 ATP2B3	4.67e-04	27	80	3	MM15053
Pathway	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	ATP2B1 ATP2B2 ATP2B3	5.20e-04	28	80	3	M924
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	USP34 RANBP2 ATRX INCENP PNN WDR70 KDM3B DPF2 RFC5 DIS3 CRNKL1 GTF2E1 BRD8 GTF3C1 WDHD1 ZNF592 SLTM HTATSF1 FIP1L1 BOD1L1	7.16e-11	1014	111	20	32416067
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	USP34 ABCF1 REPS1 ATRX PEG3 ZBTB47 NASP SEC31A HUWE1 RAD54L2 ZEB2 CRYAB CRNKL1 ZNF592 KCNJ6 NEMF FIP1L1 SPARCL1 DNAI7 MVP PCM1 RASAL2	1.06e-10	1285	111	22	35914814
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PMS1 ABCF1 SETX ATRX KDM3B RAD54L2 CWC22 DIS3 GTF3C1 NEMF SLTM CRYBG3 DDX11L8 ALG1 RASAL2 MGRN1	2.92e-10	650	111	16	38777146
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	DNHD1 RANBP2 ABCF1 ATRX INCENP PNN NASP SEC31A HUWE1 RFC5 CWC22 DIS3 CRNKL1 GTF3C1 NEMF SLTM BOD1L1 TDRD6 ATP2B1 ATP2B3 NBR1 RASAL2	7.36e-10	1425	111	22	30948266
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	PMS1 EHBP1 RANBP2 ABCF1 REPS1 ATRX PNN WDR70 KDM3B NASP DIS3 GTF2E1 KIAA1217 C1orf52 HTATSF1 BOD1L1 MAPRE2 PCM1	1.03e-09	934	111	18	33916271
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	PMS1 RANBP2 SETX CENPT ATRX INCENP PNN CWC22 CRNKL1 BRD8 SLTM HTATSF1 FIP1L1 BOD1L1 MPHOSPH10 ZCCHC7 TAF1L PCM1	1.43e-09	954	111	18	36373674
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	RANBP2 SETX ATRX DPF2 HUWE1 ZEB2 CRNKL1 GTF3C1 WDHD1 ZNF592 SLTM HTATSF1 BOD1L1	3.74e-09	469	111	13	27634302
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	PMS1 SETX CENPT ATRX INCENP WDR70 KDM3B NASP RFC5 ZEB2 GTF2E1 GTF3C1 ZNF592 BOD1L1	9.53e-09	608	111	14	36089195
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RANBP2 ABCF1 SETX INCENP PNN WDR70 SEC31A DPF2 HUWE1 RFC5 DIS3 CRNKL1 GTF3C1 PIP4K2A SLTM FIP1L1 MAPRE2 MVP ATP2B1 RASAL2	1.01e-08	1353	111	20	29467282
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	USP34 SETX ATRX PEG3 NASP ZBTB41 SEC31A HUWE1 DIS3 BRD8 WDHD1 SETD5 SLTM NADK BOD1L1 BIN2 MPHOSPH10 ATP2B1	1.04e-08	1084	111	18	11544199
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RANBP2 ABCF1 ZEB1 ATRX PNN KDM3B NASP DPF2 HUWE1 BRD8 GTF3C1 WDHD1 ZNF592 FIP1L1 PCM1	2.67e-08	774	111	15	15302935
Pubmed	Trafficking of presynaptic PMCA signaling complexes in mouse photoreceptors requires Cav1.4 α1 subunits.	CACNA1F ATP2B1 ATP2B2	3.16e-08	3	111	3	22183401
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	RANBP2 SETX WDR70 HUWE1 ZEB2 CRYAB BRD8 GTF3C1 WDHD1 FIP1L1 TSHZ1 SGF29 ATP2B1 ATP2B3 NBR1	1.00e-07	857	111	15	25609649
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	EHBP1 USP34 RANBP2 ZEB1 HUWE1 ZEB2 GTF3C1 ZNF592 ZFHX3 CRYBG3 PCM1	1.07e-07	418	111	11	34709266
Pubmed	Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons.	ATP2B1 ATP2B2 ATP2B3	1.26e-07	4	111	3	12209837
Pubmed	Expression and role of calcium-ATPase pump and sodium-calcium exchanger in differentiated trophoblasts from human term placenta.	ATP2B1 ATP2B2 ATP2B3	1.26e-07	4	111	3	12784250
Pubmed	Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling.	NPIPA1 NPIPA5 NPIPA3	1.26e-07	4	111	3	18055785
Pubmed	Calcium pumps of plasma membrane and cell interior.	ATP2B1 ATP2B2 ATP2B3	1.26e-07	4	111	3	15101689
Pubmed	The plasma membrane calcium pump in health and disease.	ATP2B1 ATP2B2 ATP2B3	1.26e-07	4	111	3	23413890
Pubmed	Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.	ATP2B1 ATP2B2 ATP2B3	1.26e-07	4	111	3	8245032
Pubmed	Plasma membrane calcium ATPases as critical regulators of calcium homeostasis during neuronal cell function.	ATP2B1 ATP2B2 ATP2B3	1.26e-07	4	111	3	10577388
Pubmed	Structural organization, ion transport, and energy transduction of P-type ATPases.	ATP2B1 ATP2B2 ATP2B3	1.26e-07	4	111	3	8634322
Pubmed	Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.	ATP2B1 ATP2B2 ATP2B3	1.26e-07	4	111	3	7989379
Pubmed	Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps.	ATP2B1 ATP2B2 ATP2B3	1.26e-07	4	111	3	11152753
Pubmed	PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†.	ATP2B1 ATP2B2 ATP2B3	1.26e-07	4	111	3	36130203
Pubmed	Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse.	ATP2B1 ATP2B2 ATP2B3	1.26e-07	4	111	3	10434059
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	CACNA1F RYR1 ATP2B1 ATP2B2 ATP2B3	1.40e-07	38	111	5	30786075
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 RANBP2 ABCF1 INCENP PNN HUWE1 DIS3 CRNKL1 GTF3C1 SLTM MPHOSPH10 MVP PCM1	1.79e-07	653	111	13	22586326
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	EHBP1 RANBP2 PNN KIAA1217 FIP1L1 CRYBG3 ATP2B3 NBR1 RASAL2	1.82e-07	263	111	9	34702444
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	USP34 ZEB1 SETX RAD54L2 DIS3 CRYAB GTF3C1 BOD1L1 SGF29 ATP2B1 ALG1	2.39e-07	453	111	11	29656893
Pubmed	Differential regulation of the apical plasma membrane Ca(2+) -ATPase by protein kinase A in parotid acinar cells.	ATP2B1 ATP2B2 ATP2B3	3.15e-07	5	111	3	17938178
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	RANBP2 NIBAN1 DPF2 GTF2E1 GTF3C1 SLTM MPHOSPH10 SGF29 MAPRE2 TAF1L	3.27e-07	370	111	10	22922362
Pubmed	Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).	KDM3B FAM13B BRD8	6.28e-07	6	111	3	11161817
Pubmed	Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange.	ATP2B1 ATP2B2 ATP2B3	6.28e-07	6	111	3	12767889
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CENPT INCENP NASP DPF2 HUWE1 BRD8 ZNF592 PIP4K2A SLTM FIP1L1 SGF29 PCM1	1.11e-06	645	111	12	25281560
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	RANBP2 ABCF1 ATRX HUWE1 RAD54L2 RFC5 GTF3C1 WDHD1 BOD1L1	1.27e-06	332	111	9	32786267
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	PMS1 RANBP2 SETX REPS1 WDR70 KDM3B RAD54L2 DIS3 GTF2E1 SLTM	1.70e-06	444	111	10	34795231
Pubmed	Gene knockout studies of Ca2+-transporting ATPases.	ATP2B1 ATP2B2 ATP2B3	1.75e-06	8	111	3	10951186
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	PMS1 ZEB1 MYT1 PEG3 KDM3B IRF6 ZBTB41 DPF2 GTF2E1 BRD8 ZNF592 SLTM ZFHX3	1.93e-06	808	111	13	20412781
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	EHBP1 SETX PSD3 KDM3B KIAA1217 NADK FIP1L1 AKAP11 BOD1L1 CRYBG3 ATP2B1 PCM1 RASAL2	3.86e-06	861	111	13	36931259
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	USP34 WDR70 KDM3B HUWE1 WDHD1 SYTL4 C1orf52 FIP1L1 BOD1L1 MAPRE2 NBR1 PCM1	4.13e-06	733	111	12	34672954
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	EHBP1 PITPNM2 ATRX MYT1 WDR70 HUWE1 GTF3C1 SETD5 KIAA1217 NEMF ZFHX3 BOD1L1 ATP2B1 NBR1 PCM1 PDZD2 MGRN1	5.02e-06	1489	111	17	28611215
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	RANBP2 ABCF1 SETX PNN NASP HUWE1 BRD8 GTF3C1 FIP1L1 PCM1	5.12e-06	503	111	10	16964243
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	USP34 SETX INCENP WDR7 KDM3B SEC31A HUWE1 SYTL4 FIP1L1 ZFHX3 PCM1 RASAL2	7.44e-06	777	111	12	35844135
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PITPNM2 USP34 SETX KDM3B CWC22 DIS3 ZNF592 AKAP11 NBR1 MGRN1	7.95e-06	529	111	10	14621295
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	ATRX PNN NASP SLTM FIP1L1 MPHOSPH10	8.41e-06	148	111	6	32538781
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	ABCF1 CENPT ATRX PNN DPF2 RFC5 CWC22 GTF3C1 ZNF592 SETD5	8.49e-06	533	111	10	30554943
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	RANBP2 DPF2 BRD8 GTF3C1 ZNF592 HTATSF1	9.08e-06	150	111	6	28242625
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	RANBP2 ABCF1 SETX PNN WDR7 SEC31A DPF2 CWC22 CRNKL1 GTF3C1 NEMF SLTM FIP1L1 MVP	9.32e-06	1082	111	14	38697112
Pubmed	ZEBs: Novel Players in Immune Cell Development and Function.	ZEB1 ZEB2	1.01e-05	2	111	2	30956067
Pubmed	Prognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis.	ZEB1 ZEB2	1.01e-05	2	111	2	28416756
Pubmed	Zfhx1a and Zfhx1b mRNAs have non-overlapping expression domains during chick and mouse midgestation limb development.	ZEB1 ZEB2	1.01e-05	2	111	2	12609600
Pubmed	Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder.	ZEB1 ZEB2	1.01e-05	2	111	2	24306957
Pubmed	Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer.	ZEB2 PDZD2	1.01e-05	2	111	2	23184150
Pubmed	Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.	ZEB1 ZEB2	1.01e-05	2	111	2	20375168
Pubmed	Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma.	ZEB1 ZEB2	1.01e-05	2	111	2	29476046
Pubmed	Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer.	ZEB1 ZEB2	1.01e-05	2	111	2	22213144
Pubmed	Functional conservation of zinc-finger homeodomain gene zfh1/SIP1 in Drosophila heart development.	ZEB1 ZEB2	1.01e-05	2	111	2	16957952
Pubmed	The mesodermal and myogenic specification of hESCs depend on ZEB1 and are inhibited by ZEB2.	ZEB1 ZEB2	1.01e-05	2	111	2	37819755
Pubmed	Localization of two genes encoding plasma membrane Ca2+ ATPases isoforms 2 (ATP2B2) and 3 (ATP2B3) to human chromosomes 3p26-->p25 and Xq28, respectively.	ATP2B2 ATP2B3	1.01e-05	2	111	2	8187550
Pubmed	Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.	ZEB1 ZEB2	1.01e-05	2	111	2	22892238
Pubmed	The Zeb proteins δEF1 and Sip1 may have distinct functions in lens cells following cataract surgery.	ZEB1 ZEB2	1.01e-05	2	111	2	25082886
Pubmed	Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway.	ZEB1 ZEB2	1.01e-05	2	111	2	20025777
Pubmed	Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.	ZEB1 ZEB2	1.01e-05	2	111	2	20424117
Pubmed	TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.	ZEB1 ZEB2	1.01e-05	2	111	2	21747944
Pubmed	The adaptive antioxidant response during fasting-induced muscle atrophy is oppositely regulated by ZEB1 and ZEB2.	ZEB1 ZEB2	1.01e-05	2	111	2	37948583
Pubmed	The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.	ZEB1 ZEB2	1.01e-05	2	111	2	28133913
Pubmed	Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity.	ZEB1 ZEB2	1.01e-05	2	111	2	34550965
Pubmed	Loss of Prox1 in striated muscle causes slow to fast skeletal muscle fiber conversion and dilated cardiomyopathy.	MYH2 MYH6 TNNT3	1.12e-05	14	111	3	24938781
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	RANBP2 ABCF1 SETX KDM3B DPF2 RAD54L2 RFC5 ZEB2 GTF3C1 C1orf52 FIP1L1 BIN2 SGF29 PCM1	1.16e-05	1103	111	14	34189442
Pubmed	Scanning the human proteome for calmodulin-binding proteins.	RANBP2 ATRX HUWE1 SLTM NBR1	1.19e-05	92	111	5	15840729
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH2 RANBP2 MYH6 ATRX PNN ZBTB41 RAD54L2 ZEB2 GTF3C1 SETD5 PIP4K2A BOD1L1 MPHOSPH10 ATP2B1 ATP2B2 ATP2B3	1.40e-05	1442	111	16	35575683
Pubmed	Mapping the Genetic Landscape of Human Cells.	PNN WDR7 WDR70 RFC5 CWC22 GTF2E1 NEMF FIP1L1 BOD1L1	1.51e-05	451	111	9	30033366
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	MYH2 RANBP2 SETX INCENP SNAPC5 GTF3C1 MPHOSPH10	1.64e-05	250	111	7	33536335
Pubmed	Characterization of human colon cancer antigens recognized by autologous antibodies.	NEMF TSHZ1 TDRD6	1.72e-05	16	111	3	9610721
Pubmed	A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.	MYH2 MYH6 TNNT3	1.72e-05	16	111	3	19922871
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	USP34 SETX ATRX HUWE1 RAD54L2 DIS3 KIAA1217 PIP4K2A CRYBG3 PCM1	1.98e-05	588	111	10	38580884
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	PNN CWC22 CRNKL1 ZNF592 ZFHX3	2.06e-05	103	111	5	32744500
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	PNN WDR70 CRNKL1 ZNF592 SLTM NADK HTATSF1 FIP1L1	2.17e-05	361	111	8	26167880
Pubmed	A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors.	ZEB1 ZEB2	3.02e-05	3	111	2	21890822
Pubmed	TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression.	ZEB1 ZEB2	3.02e-05	3	111	2	31933004
Pubmed	Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.	ZEB1 ZEB2	3.02e-05	3	111	2	24968735
Pubmed	Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran.	ZEB1 ZEB2	3.02e-05	3	111	2	31244281
Pubmed	miR-144-3p inhibited the growth, metastasis and epithelial-mesenchymal transition of colorectal adenocarcinoma by targeting ZEB1/2.	ZEB1 ZEB2	3.02e-05	3	111	2	34226299
Pubmed	Plasma Membrane Calcium ATPase-Neuroplastin Complexes Are Selectively Stabilized in GM1-Containing Lipid Rafts.	ATP2B1 ATP2B2	3.02e-05	3	111	2	34948386
Pubmed	The potential role of regulator of G-protein signaling 16 in cell motility mediated by δEF1 family proteins.	ZEB1 ZEB2	3.02e-05	3	111	2	26823172
Pubmed	A miRNA signature associated with human metastatic medullary thyroid carcinoma.	ZEB1 ZEB2	3.02e-05	3	111	2	24127332
Pubmed	p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2.	ZEB1 ZEB2	3.02e-05	3	111	2	21518799
Pubmed	miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.	ZEB1 ZEB2	3.02e-05	3	111	2	25833697
Pubmed	miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.	ZEB1 ZEB2	3.02e-05	3	111	2	26022123
Pubmed	An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition.	ZEB1 ZEB2	3.02e-05	3	111	2	21411626
Pubmed	Langerhans cell maturation is accompanied by induction of N-cadherin and the transcriptional regulators of epithelial-mesenchymal transition ZEB1/2.	ZEB1 ZEB2	3.02e-05	3	111	2	24165969
Pubmed	Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.	ZEB1 ZEB2	3.02e-05	3	111	2	23412770
Pubmed	Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.	ZEB1 ZEB2	3.02e-05	3	111	2	29052277
Pubmed	ZEB1 imposes a temporary stage-dependent inhibition of muscle gene expression and differentiation via CtBP-mediated transcriptional repression.	MYH2 ZEB1	3.02e-05	3	111	2	23339872
Pubmed	Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta.	ZEB1 ZEB2	3.02e-05	3	111	2	17615296
Pubmed	miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.	ZEB1 ZEB2	3.02e-05	3	111	2	26556542
Pubmed	Involvement of negative cofactor NC2 in active repression by zinc finger-homeodomain transcription factor AREB6.	ZEB1 GTF2E1	3.02e-05	3	111	2	9418848
Pubmed	The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.	ZEB1 ZEB2	3.02e-05	3	111	2	18376396
Pubmed	The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.	ZEB1 ZEB2	3.02e-05	3	111	2	18411277
Interaction	RSPH6A interactions	MYH2 SMYD1 RSPH6A CRYAB TNNT3	1.04e-06	34	109	5	int:RSPH6A
Interaction	NUP43 interactions	USP34 RANBP2 SETX CENPT INCENP PNN RAD54L2 CWC22 BRD8 ZNF592 ZFHX3 BOD1L1 MPHOSPH10 ZCCHC7 PDZD2	1.37e-06	625	109	15	int:NUP43
Interaction	TERF2IP interactions	PMS1 ZEB1 SETX INCENP WDR70 KDM3B NASP BRD8 GTF3C1 WDHD1 ZNF592 C1orf52 HTATSF1 BOD1L1	1.67e-06	552	109	14	int:TERF2IP
Interaction	NUP50 interactions	PMS1 RANBP2 ZEB1 WDR70 KDM3B SEC31A GTF2E1 WDHD1 C1orf52 HTATSF1 BOD1L1	2.43e-06	341	109	11	int:NUP50
Interaction	NAA40 interactions	PMS1 EHBP1 RANBP2 ABCF1 REPS1 ATRX PNN WDR70 KDM3B NASP DIS3 GTF2E1 KIAA1217 C1orf52 HTATSF1 BOD1L1 MAPRE2 PCM1	4.87e-06	978	109	18	int:NAA40
Interaction	SMC5 interactions	PMS1 RANBP2 SETX CENPT ATRX INCENP PNN CWC22 CRNKL1 BRD8 SLTM HTATSF1 FIP1L1 BOD1L1 MPHOSPH10 ZCCHC7 TAF1L PCM1	6.61e-06	1000	109	18	int:SMC5
Interaction	H3C3 interactions	PMS1 SETX ATRX INCENP WDR70 KDM3B NASP RFC5 ZEB2 GTF2E1 GTF3C1 BOD1L1	1.53e-05	495	109	12	int:H3C3
Interaction	C17orf78 interactions	ATP2B1 ATP2B2 ATP2B3	3.27e-05	12	109	3	int:C17orf78
Interaction	DDX23 interactions	PNN WDR70 CWC22 GTF2E1 WDHD1 PIP4K2A SLTM FIP1L1 MPHOSPH10 NBR1 PCM1	5.86e-05	480	109	11	int:DDX23
Interaction	H2BC8 interactions	ZEB1 CENPT ATRX INCENP WDR70 DPF2 BRD8 GTF3C1 ZNF592 C1orf52 AKAP11 SGF29	6.67e-05	576	109	12	int:H2BC8
Interaction	HSD17B6 interactions	ATP2B1 ATP2B2 ATP2B3	6.68e-05	15	109	3	int:HSD17B6
Interaction	SUPT5H interactions	SETX ATRX PNN WDR70 ZEB2 CRNKL1 GTF3C1 SETD5 HTATSF1 PCM1	7.43e-05	408	109	10	int:SUPT5H
Interaction	SSRP1 interactions	RANBP2 SETX ATRX PNN DPF2 HUWE1 RFC5 CRNKL1 WDHD1 ZNF592 SETD5 SLTM ATP2B1	8.42e-05	685	109	13	int:SSRP1
Interaction	BIRC3 interactions	DNHD1 RANBP2 ABCF1 INCENP PNN NASP SEC31A HUWE1 RFC5 CWC22 DIS3 CRNKL1 GTF3C1 SLTM TDRD6 ATP2B1 ATP2B3 NBR1 RASAL2	9.11e-05	1334	109	19	int:BIRC3
Interaction	IRF6 interactions	ABCF1 IRF6 SGF29	9.90e-05	17	109	3	int:IRF6
Interaction	PHF21A interactions	EHBP1 USP34 RANBP2 HUWE1 ZEB2 ZNF592 ZFHX3 CRYBG3 PCM1	1.03e-04	343	109	9	int:PHF21A
Interaction	FEV interactions	ZEB1 ATRX DPF2 RAD54L2 ZEB2 GTF3C1 ZFHX3	1.19e-04	203	109	7	int:FEV
Interaction	EEF1AKMT3 interactions	EHBP1 USP34 SETX PSD3 HUWE1 DIS3 GTF3C1 WDHD1 MAPRE2	1.62e-04	364	109	9	int:EEF1AKMT3
Interaction	PNISR interactions	PNN WDR7 DPF2 PIP4K2A	1.66e-04	51	109	4	int:PNISR
Cytoband	16p13.11	NPIPA1 NPIPA5 NPIPA3	2.35e-05	23	111	3	16p13.11
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZEB1 ZEB2 ZFHX3 TSHZ1	3.23e-07	15	73	4	529
GeneFamily	ATPases Ca2+ transporting	ATP2B1 ATP2B2 ATP2B3	5.21e-06	9	73	3	1209
GeneFamily	Myosin heavy chains	MYH2 MYH6 MYH16	2.77e-05	15	73	3	1098
GeneFamily	WD repeat domain containing	WDR7 WDR70 SEC31A CFAP43 WDHD1 DNAI4	6.61e-04	262	73	6	362
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	PMS1 EHBP1 USP34 RANBP2 ZEB1 SETX ATRX WDR7 PSD3 KDM3B ZEB2 WDHD1 PIP4K2A AKAP11 ZFHX3 CRYBG3 ATP2B1	1.05e-07	856	110	17	M4500
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	PMS1 USP34 ATRX PNN CWC22 WDHD1 NEMF HTATSF1 BOD1L1 MPHOSPH10 ZCCHC7 ATP2B1 RASAL2	1.06e-05	721	110	13	M10237
Coexpression	GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	USP34 RANBP2 ATRX ZEB2 WDHD1 SPON1 SPARCL1	2.15e-05	199	110	7	M8381
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP	EXOC6 KLHL24 ATRX PIP4K2A ZFHX3 BOD1L1 MAPRE2	2.22e-05	200	110	7	M8050
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	RANBP2 ABCF1 ATRX PNN MYT1 NASP IRX1 CWC22 SPON1 PIP4K2A NEMF SLTM DNAI4 BOD1L1 MPHOSPH10 ATP2B1 ATP2B2 PCM1 RASAL2	4.65e-07	989	107	19	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	ATRX PNN MYT1 NASP IRX1 CWC22 SPON1 NEMF SLTM MPHOSPH10 ATP2B2 PCM1 RASAL2	1.35e-06	498	107	13	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	RANBP2 ABCF1 ATRX PNN NASP NEMF SLTM BOD1L1 MPHOSPH10 PCM1	3.94e-06	311	107	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	RANBP2 ABCF1 ATRX PNN CNPY4 SNAPC5 NASP ZBTB41 HUWE1 NEMF SLTM DNAI4 BOD1L1 MPHOSPH10 PCM1	1.80e-05	831	107	15	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	RANBP2 ABCF1 SETX REPS1 ATRX INCENP PNN NASP NEMF SLTM MPHOSPH10	2.50e-05	469	107	11	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	PMS1 ABCF1 ZEB1 ATRX PNN PEG3 PSD3 NASP CHGB CWC22 SETD5 SPON1 SLTM C1orf52 FIP1L1 BOD1L1 MPHOSPH10 PCM1 RASAL2	5.00e-05	1370	107	19	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	ATRX PNN NASP NEMF SLTM MPHOSPH10 PCM1	5.39e-05	192	107	7	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4	ABCF1 REPS1 ATRX PNN NASP CWC22 DNAI4	5.39e-05	192	107	7	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	ABCF1 SETX ATRX NASP ZBTB41 DPF2 KANK4 FIP1L1 MGRN1	5.51e-05	339	107	9	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	RANBP2 ABCF1 SETX INCENP PNN NASP ZEB2 BRD8 NEMF SLTM MPHOSPH10	7.80e-05	532	107	11	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	ZEB1 CENPT REPS1 ATRX PNN NASP GTF2E1 GTF3C1 SETD5 SLTM BOD1L1 PCM1	7.84e-05	629	107	12	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	ABCF1 ZEB1 SETX ATRX PNN NASP GPATCH3 SETD5 SPON1 SLTM FIP1L1 DNAI4 BOD1L1 MPHOSPH10 PCM1 RASAL2	7.98e-05	1060	107	16	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_500	PEG3 NASP CHGB ZEB2 ZFHX3	8.77e-05	89	107	5	gudmap_developingGonad_e11.5_ovary + mesonephros_k1_500
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000	SETX ATRX PNN NASP HUWE1 NEMF	9.74e-05	146	107	6	gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_200	MYH2 NIBAN1 CRYAB TNNT3	1.17e-04	50	107	4	gudmap_developingLowerUrinaryTract_P1_bladder_B_200_k2
CoexpressionAtlas	geo_heart_top-relative-expression-ranked_100	MYH6 SMYD1 CRYAB HRC SPARCL1	1.52e-04	100	107	5	PCBC_ctl_geo-heart_100
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	RANBP2 ABCF1 PNN NASP NEMF SLTM MPHOSPH10	1.75e-04	232	107	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500	RANBP2 ABCF1 PNN MYT1 NASP CWC22 NEMF SLTM MPHOSPH10 ATP2B2	1.95e-04	493	107	10	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	ABCF1 ZEB1 SETX ATRX PNN NASP CHGB CWC22 GPATCH3 SETD5 SPON1 SLTM FIP1L1 DNAI4 BOD1L1 MPHOSPH10 PCM1 RASAL2	2.37e-04	1414	107	18	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#2_top-relative-expression-ranked_500	NIBAN1 HRC SPARCL1 MAPRE2	3.26e-04	65	107	4	gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k2_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	NIBAN1 PEG3 PSD3 PALMD ZEB2 SYTL4 KANK4 AKAP11 TSHZ1 SPARCL1 ATP2B3 PDZD2	3.52e-04	740	107	12	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	INCENP PNN NASP SLTM BOD1L1 PCM1	3.62e-04	186	107	6	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305	USP34 KLHL24 SETX ATRX PEG3 ZEB2 NEMF	4.02e-04	266	107	7	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_200	MYH2 NIBAN1 CRYAB TNNT3	4.10e-04	69	107	4	gudmap_developingLowerUrinaryTract_P1_bladder_J_200_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	CACNA1F CENPT REPS1 ATRX PNN MYT1 NASP CWC22 SLTM KANK4 ZFHX3 BOD1L1 ATP2B2 PCM1	4.43e-04	989	107	14	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	geo_heart_top-relative-expression-ranked_1000	MYH6 NIBAN1 SMYD1 PEG3 ZBTB47 PALMD CHGB CRYAB CTNNA3 HRC BIN2 SPARCL1 TNNT3 PDZD2	4.48e-04	990	107	14	PCBC_ctl_geo-heart_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	INCENP PNN PSD3 NASP CWC22 SLTM PCM1	4.49e-04	271	107	7	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	ABCF1 ZEB1 SETX ATRX PNN PEG3 NASP SETD5 NEMF SLTM C1orf52 ZFHX3 BOD1L1 TSHZ1 MPHOSPH10 PCM1	4.76e-04	1241	107	16	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX NASP ZEB2 BRD8 KIAA1217 FIP1L1 ATP2B1	5.12e-04	277	107	7	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	EHBP1 ZEB1 PEG3 PSD3 PALMD CWC22 ZEB2 CRYAB KIAA1217 KANK4 SPARCL1 PDZD2	5.44e-04	777	107	12	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	PMS1 ABCF1 ZEB1 SETX ATRX INCENP PNN NASP SETD5 NEMF SLTM FIP1L1 ZFHX3 BOD1L1 MPHOSPH10 PCM1	5.47e-04	1257	107	16	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_200	ATRX NASP ZEB2 ATP2B1	5.92e-04	76	107	4	gudmap_developingGonad_e16.5_epididymis_200_k4
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	ZEB1 PEG3 PSD3 PALMD CWC22 SYTL4 KIAA1217 KANK4 TSHZ1 SPARCL1 ATP2B3 PDZD2	6.81e-04	797	107	12	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	ATRX PEG3 NASP HUWE1 ZEB2 BRD8 KIAA1217 FIP1L1 ZFHX3 ZCCHC7 ATP2B1 RASAL2	7.35e-04	804	107	12	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#1_top-relative-expression-ranked_1000	ATRX PNN ZEB2 SPON1 KANK4	7.67e-04	142	107	5	gudmap_developingKidney_e15.5_1000_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	PMS1 CACNA1F ZEB1 CENPT REPS1 ATRX CRNKL1 GTF3C1 SETD5 BOD1L1	8.51e-04	595	107	10	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	PEG3 PSD3 ZBTB41 HUWE1 ZEB2 CRNKL1 PIP4K2A ZFHX3 MAPRE2	8.62e-04	492	107	9	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500	ABCF1 REPS1 ATRX PNN NASP CWC22 KANK4 DNAI4 ZFHX3	8.62e-04	492	107	9	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PITPNM2 USP34 ZEB1 SETX ATRX PALMD FAM13B KIAA1217 SPARCL1 FAM124B	8.39e-11	200	111	10	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PITPNM2 EXOC6 ZEB1 SETX ATRX PALMD KIAA1217 SPARCL1 FAM124B MAPRE2	8.39e-11	200	111	10	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RANBP2 MYH6 ATRX PNN PEG3 SEC31A ZEB2 CRYAB PCM1	6.27e-10	176	111	9	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH6 NIBAN1 ZEB1 SMYD1 PSD3 PALMD CTNNA3 SPARCL1 PDZD2	1.23e-09	190	111	9	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX PEG3 SEC31A HUWE1 BOD1L1 TSHZ1 ZCCHC7 ATP2B1 PCM1	1.55e-09	195	111	9	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX PEG3 SEC31A HUWE1 BOD1L1 TSHZ1 ZCCHC7 ATP2B1 PCM1	1.55e-09	195	111	9	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SMYD1 CCER2 RYR1 CRYAB SPON1 KANK4 HRC TNNT3	3.25e-08	195	111	8	80b973d2a23ef9b101c90e1635e68c9a3f78f65d
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	PITPNM2 EXOC6 ZEB1 SETX PALMD KIAA1217 FAM124B MAPRE2	3.95e-08	200	111	8	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_only / Treatment groups by lineage, cell group, cell type	PITPNM2 ZEB1 SETX PALMD KIAA1217 SPARCL1 FAM124B MAPRE2	3.95e-08	200	111	8	b1fadb2b5e37e0f51e079d8409c2647eef68dc3b
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PITPNM2 ZEB1 SETX PALMD KIAA1217 SPARCL1 FAM124B MAPRE2	3.95e-08	200	111	8	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NIBAN1 CRYAB SPON1 CTNNA3 HRC ZFHX3 TNNT3	5.59e-07	193	111	7	469a7f1c2ff7137cc5a064464456911f67f92e70
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZEB2 CRYAB SPON1 HRC ZFHX3 SPARCL1 PDZD2	5.99e-07	195	111	7	6e875c83f838241b5fcaf4a3249b1408d74521dc
ToppCell	COVID-19-Heart-Mito_CM\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH2 MYH6 SMYD1 CRYAB CTNNA3 HRC TNNT3	6.41e-07	197	111	7	44e49943d62bfe622b40ad0460093d31540544df
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 SETX ATRX PNN ZEB2 BOD1L1 PCM1	7.09e-07	200	111	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PITPNM2 ZEB1 SETX PALMD KIAA1217 FAM124B MAPRE2	7.09e-07	200	111	7	a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PITPNM2 ZEB1 SETX PALMD KIAA1217 FAM124B MAPRE2	7.09e-07	200	111	7	89a6da2bdedc6b1ad0675c8753bf2b763a99af6a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PITPNM2 ZEB1 SETX PALMD KIAA1217 FAM124B MAPRE2	7.09e-07	200	111	7	b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PITPNM2 ZEB1 SETX PALMD KIAA1217 FAM124B MAPRE2	7.09e-07	200	111	7	58a7ece7dfdf6c46f2a50cbcb580574dec14c748
ToppCell	LPS_IL1RA_TNF-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PITPNM2 ZEB1 SETX PALMD KIAA1217 FAM124B MAPRE2	7.09e-07	200	111	7	d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3\|Control_saline / Treatment groups by lineage, cell group, cell type	NIBAN1 ZEB2 CRYAB CTNNA3 ZFHX3 SPARCL1 TNNT3	7.09e-07	200	111	7	b0866b497aa71d06cef25f9a335fa584e95fa7e0
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_only / Treatment groups by lineage, cell group, cell type	NIBAN1 CRYAB CTNNA3 ZFHX3 SPARCL1 TNNT3 MAPRE2	7.09e-07	200	111	7	7c62678cf408aaaf98d6df0fb27814d2007c4521
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal\|6m / Sample Type, Dataset, Time_group, and Cell type.	SMYD1 RYR1 HRC DNAI4 DNAI7 TNNT3 ATP2B3	7.09e-07	200	111	7	13ec8afea86e4a10599c924871ba4e325b0a8013
ToppCell	droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH2 CHGB SPON1 CTNNA3 HRC TNNT3	5.84e-06	179	111	6	4135f9e8cd8494cbc189e5210dded84659643fb8
ToppCell	E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NIBAN1 CRYAB SPON1 CTNNA3 HRC SPARCL1	6.03e-06	180	111	6	38035cf2c6fbc443ea10ca7e942572715ed572da
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NIBAN1 IRX1 CTNNA3 KANK4 HRC ZFHX3	6.22e-06	181	111	6	59527ad218e49386b04cabb97d53d2ed55a35961
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH6 NIBAN1 SMYD1 PSD3 PALMD CTNNA3	7.05e-06	185	111	6	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NIBAN1 ZEB1 ZEB2 ZFHX3 SPARCL1 RASAL2	7.05e-06	185	111	6	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ZEB1 ZEB2 SPON1 KANK4 ZFHX3 SPARCL1	7.05e-06	185	111	6	9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NIBAN1 ZEB1 ZEB2 ZFHX3 SPARCL1 RASAL2	7.05e-06	185	111	6	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NIBAN1 CRYAB CTNNA3 HRC ZFHX3 TNNT3	7.27e-06	186	111	6	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NIBAN1 CRYAB SPON1 CTNNA3 HRC ZFHX3	7.73e-06	188	111	6	6ec22b79b19d57ea187f312907819dc2d01f3efe
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZEB1 PALMD KIAA1217 SPARCL1 TNNT3 RASAL2	7.97e-06	189	111	6	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	droplet-Heart-nan-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH6 PEG3 ZEB2 CRYAB SPON1 HRC	8.21e-06	190	111	6	96a92212ea3fb35fa3d0da495e504edc61c71c23
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	KLHL24 MYH6 NIBAN1 PSD3 CTNNA3 PDZD2	8.21e-06	190	111	6	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	COVID-19-Heart-Mito_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH2 PALMD RYR1 HRC SPARCL1 TNNT3	8.21e-06	190	111	6	ea74e0e38bcaba125b48c88331e9ba09228d3178
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	KLHL24 MYH6 NIBAN1 PSD3 CTNNA3 PDZD2	8.46e-06	191	111	6	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 EXOC6 ZEB1 PALMD KIAA1217 FAM124B	8.98e-06	193	111	6	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 EXOC6 ZEB1 PALMD KIAA1217 FAM124B	8.98e-06	193	111	6	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	USP34 RANBP2 ATRX ZBTB41 HUWE1 CRYBG3	8.98e-06	193	111	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NIBAN1 CRYAB CTNNA3 HRC ZFHX3 PDZD2	8.98e-06	193	111	6	88916d9a7d831eb52848599917c04238f8f9812b
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 PALMD KIAA1217 SPARCL1 FAM124B RASAL2	8.98e-06	193	111	6	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NIBAN1 SPON1 HRC SPARCL1 TNNT3 PDZD2	8.98e-06	193	111	6	800b0f5705fefcd3608e37801afae8a94474723e
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CRYAB SPON1 HRC ZFHX3 SPARCL1 PDZD2	8.98e-06	193	111	6	7386fadc13a437f3b0c99b5d116cd3c5f893529c
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 ZEB1 PALMD KIAA1217 FAM124B RASAL2	9.25e-06	194	111	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	MYH6 NIBAN1 PSD3 CTNNA3 MAPRE2 PDZD2	9.25e-06	194	111	6	c3535f7cc0076653c72db582047cff053c322397
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH2 NIBAN1 SPON1 HRC ZFHX3 TNNT3	9.52e-06	195	111	6	43d372373367b71243c6ea958aedccde4478618f
ToppCell	CV-Moderate-6\|Moderate / Virus stimulation, Condition and Cluster	ABCF1 ATRX HUWE1 GTF3C1 BOD1L1 BIN2	9.52e-06	195	111	6	2b8a72d7e755b9655c7a496000d10ff06e50862b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NIBAN1 ZEB1 ZEB2 ZFHX3 SPARCL1 RASAL2	9.80e-06	196	111	6	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NIBAN1 CRYAB CTNNA3 HRC ZFHX3 SPARCL1	1.01e-05	197	111	6	d16bb765afdc02406ffd7ce6a75bae72b66db66c
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	ZEB1 ATRX PNN NEMF SLTM BOD1L1	1.01e-05	197	111	6	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NIBAN1 CRYAB CTNNA3 HRC ZFHX3 SPARCL1	1.01e-05	197	111	6	68c23c23b6924892f4c238cf2f5abc7927e04fbc
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	USP34 EXOC6 RANBP2 ATRX ZFHX3 PCM1	1.04e-05	198	111	6	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	USP34 EXOC6 RANBP2 ATRX ZFHX3 PCM1	1.04e-05	198	111	6	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	USP34 EXOC6 RANBP2 ATRX ZFHX3 PCM1	1.04e-05	198	111	6	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PITPNM2 KLHL24 PNN NASP ZEB2 ZCCHC7	1.07e-05	199	111	6	dd94e42b62af7cbd69c472681d3c758552694ae2
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	PITPNM2 ZEB1 PALMD KIAA1217 SPARCL1 FAM124B	1.10e-05	200	111	6	eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NIBAN1 CRYAB CTNNA3 ZFHX3 SPARCL1 TNNT3	1.10e-05	200	111	6	a3a1e35934d676c39f917652e50c502cb2f613c1
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ZEB2 CRYAB CTNNA3 ZFHX3 SPARCL1 TNNT3	1.10e-05	200	111	6	b22cae282591d8dead9869c2adbb9632615f50f7
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NIBAN1 CRYAB CTNNA3 ZFHX3 SPARCL1 TNNT3	1.10e-05	200	111	6	c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ZEB1 PALMD KIAA1217 SPARCL1 FAM124B MAPRE2	1.10e-05	200	111	6	f15fffefe372005c33e31845982e2d2714ac26af
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	NIBAN1 CRYAB CTNNA3 ZFHX3 SPARCL1 TNNT3	1.10e-05	200	111	6	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	LPS_anti-TNF-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PITPNM2 ZEB1 SETX PALMD KIAA1217 FAM124B	1.10e-05	200	111	6	1d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCell	LPS_anti-TNF-Endothelial-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PITPNM2 ZEB1 SETX PALMD KIAA1217 FAM124B	1.10e-05	200	111	6	60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	ZEB2 CRYAB CTNNA3 ZFHX3 TSHZ1 SPARCL1	1.10e-05	200	111	6	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	PSD3 ZEB2 SYTL4 SPON1 SPARCL1 ATP2B1	1.10e-05	200	111	6	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	LPS_IL1RA-Mesenchymal_myocytic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ZEB2 CRYAB CTNNA3 ZFHX3 SPARCL1 TNNT3	1.10e-05	200	111	6	77631c471cc5d453a749784f838cfa6408caf09b
ToppCell	normal_Pleural_Fluid-T/NK_cells-CD4+_Th\|T/NK_cells / Location, Cell class and cell subclass	EXOC6 DRICH1 WDR70 RYR1 DNAI4	5.68e-05	164	111	5	334f376350c9cf92611d0f75b2e18a102f4c116a
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZEB1 SYTL4 SPARCL1 DNAI7 FAM124B	6.37e-05	168	111	5	55c9de7b3a1d6cf7b02b020ff92ab4ede8d195cc
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZEB2 HRC ZFHX3 SPARCL1 PDZD2	6.73e-05	170	111	5	1f994b690e881106a5d54b3080ccce6260bc3ac5
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NIBAN1 SPON1 CTNNA3 HRC TNNT3	7.31e-05	173	111	5	5c55e1e27e9e3e77600d378cc87b51cc73907527
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CRYAB SPON1 CTNNA3 HRC ZFHX3	7.52e-05	174	111	5	778e0317c0c63fa4efd74114feb760975b819d92
ToppCell	droplet-Liver-LIVER_HEP-30m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH2 CHGB CTNNA3 FAM124B TNNT3	7.52e-05	174	111	5	ecdff386d7f0bc57c170a2c1f4deae5ba7e431b5
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NIBAN1 CRYAB HRC ZFHX3 SPARCL1	7.93e-05	176	111	5	90f36f10c6ed440a0ca549f23219398853f1fbc3
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH6 NIBAN1 SMYD1 CRYAB CTNNA3	7.93e-05	176	111	5	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	CRYAB SPON1 NPIPA3 SPARCL1 TDRD6	7.93e-05	176	111	5	bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CRYAB SPON1 NPIPA3 SPARCL1 TDRD6	8.15e-05	177	111	5	3d955ea938a1d2fb1b6d68d4997fd454bd632dfc
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NIBAN1 NASP SPON1 CTNNA3 ZFHX3	8.15e-05	177	111	5	4553ee8cd9c24db6511b09fe49ed11a89e7cde9e
ToppCell	droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH2 CHGB CTNNA3 HRC TNNT3	8.37e-05	178	111	5	d3cbdec9d75f076e565baca05ede292cca7758a4
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1 PEG3 SEC31A SYTL4 AKAP11	8.37e-05	178	111	5	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZEB1 PALMD KIAA1217 FAM124B PDZD2	8.59e-05	179	111	5	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	LV\|World / Chamber and Cluster_Paper	KLHL24 SMYD1 PALMD CTNNA3 PDZD2	8.82e-05	180	111	5	5ac6f485a58bb29462fec02dfbe8eb70864eafe3
ToppCell	Bronchial_Biopsy-Mesenchymal-Smooth_muscle\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	ZEB1 ZEB2 CRYAB CTNNA3 HRC	8.82e-05	180	111	5	7085a851807e6a833965e1366946db0bbc5174e2
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-B\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYT1 RSPH6A CHGB KCNJ6 NPIPA3	9.05e-05	181	111	5	c1fad1f03468523e563c039be520dcf7717f90cd
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH6 NIBAN1 SMYD1 PALMD CTNNA3	9.05e-05	181	111	5	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETX ATRX ZEB2 ZCCHC7 PCM1	9.78e-05	184	111	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	PSD3 PALMD CRYAB CTNNA3 PDZD2	9.78e-05	184	111	5	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	EXOC6 ZEB1 PALMD SPARCL1 PDZD2	9.78e-05	184	111	5	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH6 NIBAN1 SMYD1 PALMD CTNNA3	9.78e-05	184	111	5	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	MS-matDC\|MS / Condition, Cell_class and T cell subcluster	CRYAB ERICH6B KCNJ6 SPARCL1 ATP2B3	1.00e-04	185	111	5	46bd897349598d85e718e25f9a045d2247723c61
ToppCell	MS-matDC-\|MS / Condition, Cell_class and T cell subcluster	CRYAB ERICH6B KCNJ6 SPARCL1 ATP2B3	1.00e-04	185	111	5	9fbe70d3a7b106fb31e13b7f95029785f28ca6f4
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ZEB1 ZEB2 KANK4 ZFHX3 SPARCL1	1.03e-04	186	111	5	7def03dd856b765bd3f493288641981c4f7fd26e
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	USP34 KLHL24 SETX ATRX BOD1L1	1.03e-04	186	111	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NIBAN1 ZEB1 ZEB2 CTNNA3 HRC	1.05e-04	187	111	5	48bfdb3504c3fefe5db3abac4b790c369680ab4e
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ZEB1 ZEB2 SPON1 KANK4 ZFHX3	1.05e-04	187	111	5	13731298bc562ec29582f5da1b4c97261284f6f1
ToppCell	Endothelial-A-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	EXOC6 ZEB1 PALMD SPARCL1 FAM124B	1.05e-04	187	111	5	fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NIBAN1 ZEB1 ZEB2 CTNNA3 HRC	1.05e-04	187	111	5	958402fcc78f4c7a7d13d659d776f3817137975f
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	USP34 RANBP2 HUWE1 ZEB2 MAPRE2	1.08e-04	188	111	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PITPNM2 ZEB1 PALMD KIAA1217 SPARCL1	1.08e-04	188	111	5	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	Control-Endothelial_cells\|Control / group, cell type (main and fine annotations)	EXOC6 ZEB1 PALMD KIAA1217 SPARCL1	1.08e-04	188	111	5	3953b08abfea93468fc8d177bdb16ca7c6ffa1ab
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NIBAN1 CRYAB CTNNA3 HRC ZFHX3	1.08e-04	188	111	5	c2321a3a1d9603f8b4b4fc09707eb32ec1e04f3f
Computational	Muscle genes.	RYR1 CRYAB HRC TNNT3	8.75e-05	37	69	4	MODULE_512
Computational	Neighborhood of DFFA	REPS1 WDR70 KDM3B CRNKL1 C1orf52 BOD1L1	1.72e-04	129	69	6	GCM_DFFA
Computational	Genes in the cancer module 387.	RYR1 CRYAB HRC TNNT3	2.65e-04	49	69	4	MODULE_387
Computational	Genes in the cancer module 201.	RYR1 CRYAB HRC TNNT3	2.87e-04	50	69	4	MODULE_201
Computational	Genes in the cancer module 329.	RYR1 CRYAB HRC TNNT3	3.10e-04	51	69	4	MODULE_329
Computational	Neighborhood of TPR	ATRX KDM3B SEC31A HUWE1 ZNF592 HTATSF1	3.49e-04	147	69	6	MORF_TPR
Computational	Neighborhood of TTN	MYH2 RYR1 TNNT3	5.92e-04	26	69	3	GNF2_TTN
Computational	Genes in the cancer module 330.	RYR1 CRYAB HRC	7.39e-04	28	69	3	MODULE_330
Computational	Neighborhood of DDB1	EHBP1 ABCF1 SNAPC5 KDM3B SEC31A HUWE1 BRD8	9.73e-04	246	69	7	MORF_DDB1
Drug	Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; PC3; HT_HG-U133A	USP34 INCENP SNAPC5 NASP PALMD DIS3 NADK MVP PCM1	3.72e-07	194	108	9	4648_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	EHBP1 KLHL24 SNAPC5 PSD3 RFC5 HTATSF1 ATP2B1 PCM1	3.51e-06	190	108	8	4306_DN
Drug	Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A	USP34 PSD3 WDHD1 ZNF592 NADK MAPRE2 RASAL2 MGRN1	4.93e-06	199	108	8	2807_DN
Drug	1sqc	ATP2B1 ATP2B2 ATP2B3	1.22e-05	10	108	3	CID000444279
Drug	2,5-dimethylquinone	ATP2B1 ATP2B2 ATP2B3	1.67e-05	11	108	3	CID000008718
Drug	1vyq	ATP2B1 ATP2B2 ATP2B3	2.21e-05	12	108	3	CID004369390
Drug	Ro 46861	ATP2B1 ATP2B2 ATP2B3	2.21e-05	12	108	3	CID000003128
Drug	Succimer	PMS1 USP34 ATRX PNN CWC22 FAM13B ZEB2 BRD8 WDHD1 SYTL4 PIP4K2A NEMF SLTM FIP1L1 ZCCHC7 MAPRE2 ATP2B1 PCM1	2.65e-05	1264	108	18	ctd:D004113
Drug	mag-fura-2	RYR1 ATP2B1 ATP2B2 ATP2B3	2.80e-05	37	108	4	CID000123839
Drug	8-hydroxycoumarin	ATP2B1 ATP2B2 ATP2B3	2.87e-05	13	108	3	CID000122783
Drug	p-hydroxyhippuric acid	ATP2B1 ATP2B2 ATP2B3	3.64e-05	14	108	3	CID000151012
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A	EHBP1 KLHL24 INCENP SNAPC5 PSD3 HTATSF1 PCM1	3.70e-05	192	108	7	4311_DN
Drug	dihydropyridine	CACNA1F MYH6 RYR1 ATP2B1 ATP2B2 ATP2B3 MGRN1	3.82e-05	193	108	7	CID000104822
Drug	Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	INCENP PSD3 PALMD RFC5 WDHD1 GPATCH3 HTATSF1	3.95e-05	194	108	7	4308_DN
Drug	Magnetite Nanoparticles	PMS1 USP34 ATRX PNN CWC22 FAM13B ZEB2 BRD8 WDHD1 SYTL4 PIP4K2A NEMF SLTM FIP1L1 ZCCHC7 MAPRE2 ATP2B1 PCM1	4.24e-05	1310	108	18	ctd:D058185
Drug	Clopamide [636-54-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ATRX INCENP SNAPC5 IRF6 RAD54L2 DIS3 NADK	4.35e-05	197	108	7	3220_DN
Drug	Danazol [17230-88-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	USP34 INCENP ZFHX3 MVP ATP2B1 PCM1 RASAL2	4.49e-05	198	108	7	1538_DN
Drug	Gibberellic acid [77-06-5]; Up 200; 11.6uM; HL60; HT_HG-U133A	CNPY4 HUWE1 SPON1 PIP4K2A ZFHX3 MVP RASAL2	4.49e-05	198	108	7	2910_UP
Drug	chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A	ZEB1 INCENP PEG3 ZFHX3 MAPRE2 MVP RASAL2	4.49e-05	198	108	7	4441_DN
Drug	Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A	CENPT PSD3 PALMD GPATCH3 ZNF592 ZFHX3 PCM1	4.79e-05	200	108	7	5853_DN
Drug	Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; PC3; HT_HG-U133A	SETX SNAPC5 NASP PALMD DIS3 MAPRE2 PCM1	4.79e-05	200	108	7	4618_DN
Drug	Thimerosal	EHBP1 PITPNM2 USP34 EXOC6 KLHL24 SETX REPS1 ATRX NASP CRYAB SYTL4 HTATSF1 AKAP11 BOD1L1 TDRD6 FAM124B PCM1	4.83e-05	1199	108	17	ctd:D013849
Drug	AC1L88YH	ATP2B1 ATP2B2 ATP2B3	6.72e-05	17	108	3	CID000374551
Drug	AC1MMLID	RYR1 GTF3C1 ATP2B1 ATP2B2 ATP2B3	7.75e-05	92	108	5	CID000013245
Disease	Hailey-Hailey disease (implicated_via_orthology)	ATP2B1 ATP2B2 ATP2B3	8.94e-07	6	106	3	DOID:0050429 (implicated_via_orthology)
Disease	atrial fibrillation	USP34 MYH6 PALMD FAM13B SPON1 CTNNA3 ZFHX3 PCM1	5.98e-05	371	106	8	EFO_0000275
Disease	cardiomyopathy (implicated_via_orthology)	MYH2 MYH6 SPARCL1 TNNT3	1.27e-04	71	106	4	DOID:0050700 (implicated_via_orthology)
Disease	suberic acid measurement	PSD3 PDZD2	2.65e-04	7	106	2	EFO_0010534
Disease	coronary artery disease	EHBP1 EXOC6 ZEB1 REPS1 CNPY4 PSD3 RSPH6A IRX1 ZEB2 KIAA1217 MPHOSPH10 MAPRE2 ATP2B1	3.55e-04	1194	106	13	EFO_0001645
Disease	pulse pressure measurement	USP34 MYH6 WDR7 MYT1 ZBTB41 CWC22 SNX19 KIAA1217 PIP4K2A CTNNA3 NADK ZFHX3 ATP2B1 PCM1	4.62e-04	1392	106	14	EFO_0005763
Disease	bitter beverage consumption measurement	NIBAN1 ZCCHC7 FAM124B	4.67e-04	42	106	3	EFO_0010089
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH2 MYH6	5.65e-04	10	106	2	DOID:0110454 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH2 MYH6	5.65e-04	10	106	2	DOID:0111269 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH2 MYH6	5.65e-04	10	106	2	DOID:0080719 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH2 MYH6	5.65e-04	10	106	2	DOID:0111602 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH2 MYH6	5.65e-04	10	106	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH2 MYH6	5.65e-04	10	106	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH2 MYH6	5.65e-04	10	106	2	DOID:0080326 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH2 MYH6	5.65e-04	10	106	2	DOID:0111596 (implicated_via_orthology)
Disease	body weight	EHBP1 KLHL24 WDR70 HUWE1 RFC5 CWC22 KIAA1217 PIP4K2A CTNNA3 NADK ZFHX3 PCM1 PDZD2	5.94e-04	1261	106	13	EFO_0004338
Disease	complement factor H-related protein 4 measurement	ZBTB41 RFC5 SPON1	7.36e-04	49	106	3	EFO_0600091
Disease	distal myopathy (implicated_via_orthology)	MYH2 MYH6	8.24e-04	12	106	2	DOID:11720 (implicated_via_orthology)
Disease	metabolite measurement, body weight gain	ZFHX3 ZCCHC7	8.24e-04	12	106	2	EFO_0004566, EFO_0004725
Disease	myotonia congenita (implicated_via_orthology)	MYH2 MYH6	8.24e-04	12	106	2	DOID:2106 (implicated_via_orthology)
Disease	rheumatic heart disease (biomarker_via_orthology)	ZEB1 ZEB2	8.24e-04	12	106	2	DOID:0050827 (biomarker_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH2 MYH6	9.72e-04	13	106	2	DOID:397 (implicated_via_orthology)
Disease	glycerol-3-phosphate measurement	NBPF3 CFAP43	1.30e-03	15	106	2	EFO_0010488
Disease	distal arthrogryposis (implicated_via_orthology)	MYH2 MYH6	1.30e-03	15	106	2	DOID:0050646 (implicated_via_orthology)
Disease	essential tremor	EHBP1 PSD3 CWC22 CTNNA3	1.49e-03	136	106	4	EFO_0003108
Disease	myocardial infarction	EHBP1 RSPH6A IRX1 ZEB2 ATP2B1 PDZD2	1.68e-03	350	106	6	EFO_0000612
Disease	peripheral neuropathy, response to docetaxel trihydrate	IRX1 CTNNA3	2.10e-03	19	106	2	EFO_0003100, GO_1902519
Disease	mean arterial pressure	NIBAN1 WDR7 KIAA1217 ZFHX3 ZCCHC7 TNNT3 ATP2B1	2.19e-03	499	106	7	EFO_0006340
Disease	Pseudoaphakia	CRYAB ATP2B1	3.35e-03	24	106	2	C0524524
Disease	Lens Opacities	CRYAB ATP2B1	3.35e-03	24	106	2	C1510497

Protein segments in the cluster

Peptide	Gene	Start	Entry
KEEEYLGKEEHLEEE	ERICH6B	81	Q5W0A0
IQDQSEEEEEEEKHP	ABCF1	136	Q8NE71
QEKTIEEQLDEEHLE	AKAP2	246	Q9Y2D5
IKQRHEEDDEEEEEE	CFAP43	951	Q8NDM7
ITDGEEKTEGEEEQE	CNPY4	206	Q8N129
VKHEENGLVFEDSEE	ALG1	401	Q9BT22
ADEEEEEEEAAVLHK	CRYBG3	2146	Q68DQ2
DFEETENKGIHELVD	BRD8	486	Q9H0E9
DKDEEHEDEVEGLGQ	AKAP11	1791	Q9UKA4
KDHQESEEEEEEERV	DNHD1	2691	Q96M86
EGEETLESDDEKDEH	C1orf52	151	Q8N6N3
VSEDDEEEEKGGTHV	RAD54L2	221	Q9Y4B4
GEDNSEIKELLEEEE	BIN2	306	Q9UBW5
GIVIVKVEEEDEEDH	FAM200A	21	Q8TCP9
IPEEELAEDVEEIDH	ATP2B1	1081	P20020
EEELNEDVEEIDHAE	ATP2B2	1106	Q01814
EELAEGEEEIDHAER	ATP2B3	1081	Q16720
DEDGSDEEVVHNEDI	RANBP2	2896	P49792
DVIEVHGKHEERQDE	CRYAB	96	P02511
EHGEKERQVSEAEEN	NPIPA1	156	Q9UND3
GQEGVEEEDEKDLET	CACNA1F	1646	O60840
HAELVVIDDEEEEDE	PALMD	441	Q9NP74
DEDKEEHETPVEVEL	NEMF	706	O60524
AVSELDEEQHLEDEE	INCENP	456	Q9NQS7
QHAELETEEEEKNLE	KCNJ6	391	P48051
PIHEEDEEKLSEDVD	MGRN1	461	O60291
EEEEEDEKLEHIEEL	FAM13B	236	Q9NYF5
LDHEDEENEDEPKVI	FAM13B	651	Q9NYF5
EEGEEDEEGQKVTIH	CWC22	431	Q9HCG8
PEEEVGKEEEEESHS	GPATCH3	276	Q96I76
KKQAHFEEEEEEEEE	NADK	431	O95544
QEIHVAQGEDDEEEE	PCM1	611	Q15154
HNDVEIEEAGEEEEK	PNN	326	Q9H307
EEEEKEIAIVHSDAE	PNN	336	Q9H307
EIAIVHSDAEKEQEE	PNN	341	Q9H307
EEAEASLEHEEGKIL	MYH2	1551	Q9UKX2
LHKEDPSESEEEQIE	PDZD2	1586	O15018
DDEDDVHVTIGDIKT	FIP1L1	91	Q6UN15
EDVEETEQNLDEAKH	RASAL2	971	Q9UJF2
AHDEEVLKTIDEGDA	KDM3B	1581	Q7LBC6
NVHDDELDSNKEDDE	MPHOSPH10	281	O00566
EHGEKERQVSEAEEN	NPIPA3	156	F8WFD2
NEDGEEATELVKHEA	PITPNM2	261	Q9BZ72
ILDPEDEEEHTQEED	HUWE1	2406	Q7Z6Z7
KHSLEEEDENEEEIL	EXOC6	261	Q8TAG9
EEGEDEEKVSHQAGD	MVP	341	Q14764
EGVHVEEEEGEKTED	NASP	111	P49321
KELHLEEEEEDEAAA	PEG3	1351	Q9GZU2
EKDLDEEGSEKELHE	HTATSF1	571	O43719
IIPENESDHEQEEEK	NBPF3	311	Q9H094
GHSVEADPKEVEEEE	BOD1L1	2751	Q8NFC6
EELEDVSDLEEEHEV	CTNNA3	631	Q9UI47
IEDHVEGLDDEEEGE	ANP32C	156	O43423
SLLDHKEEEELTEEE	ATRX	2256	P46100
EKEDAEHHPDEDVDE	CRNKL1	831	Q9BZJ0
LLHLQVQGEEKEEDE	FAM124B	436	Q9H5Z6
EDVSQHEEFLELDKD	KLHL24	196	Q6TFL4
GHRQLHQEEDEEEEK	CCER2	126	I3L3R5
KEEEEDQDIQGEISH	CENPJ	1141	Q9HC77
DEVEPLHDGVEEAEK	CENPT	321	Q96BT3
VDEDEDDLEEEHITK	DDX11L8	216	A8MPP1
GSHLIQEEEIKVEEE	DNAI7	306	Q6TDU7
KQAEEEDEHLERTLE	EHBP1	1201	Q8NDI1
EEHEGHTEEPEAEEQ	MAPRE2	301	Q15555
EPEDVLESAKHEEVE	DNAI4	436	Q5VTH9
HEEVEEESKKEEEEE	DNAI4	446	Q5VTH9
EESKKEEEEEIHAEE	DNAI4	451	Q5VTH9
LEDKEDEHNAREAEV	KANK4	261	Q5T7N3
HSEKSQREDEEEEEG	CHGB	156	P05060
DLSKAGEQEEEEEEV	RYR1	3676	P21817
NKDHIDESGENEEEA	PMS1	471	P54277
KDEEEEDDDDIHITA	DRICH1	196	Q6PGQ1
HDVERAEQEEVECEE	PIP4K2A	281	P48426
VDEEDEEDELDQSQH	IRF6	141	O14896
AHGEEEGEEDEEKAV	RSPH6A	386	Q9H0K4
AVAVHKREEDEEEDD	GTF2E1	371	P29083
EEEEEEDIDHLVKLH	SYTL4	306	Q96C24
KEEDHAGTFQIIDEE	SPON1	106	Q9HCB6
VNDEQDDEAEKHPEV	REPS1	641	Q96D71
DKIDTEELEGELECH	TDRD6	1786	O60522
GNEKEEIIHIAEEEA	NBR1	686	Q14596
EHGEKERQVSEAEEN	NPIPA5	156	E9PKD4
LEHVVEEEKVDISED	RFC5	186	P40937
EEQEEELEKTVIHND	TAF1L	1316	Q8IZX4
ESIDIDKIDEHDGDQ	IRX1	226	P78414
VEHFGEEEQKDLRVD	SMYD1	136	Q8NB12
AHELIEAEGIEDIEK	SLTM	151	Q9NWH9
EEEEEDGTLKQHKEA	KIAA1217	1606	Q5T5P2
EEKEEVIDDQENLAH	SETD5	491	Q9C0A6
ELIHGKDTVEVEEDS	SETX	1521	Q7Z333
HGLVDEEEEEEEITV	HRC	371	P23327
HGLSLNQEEEEEEDK	HRC	526	P23327
LEEAEASLEHEEGKI	MYH6	1546	P13533
HDEGQNEEDVEKEEE	DIS3	311	Q9Y2L1
GESHVPQENEEEEEK	NIBAN1	736	Q9BZQ8
EVDDIDEEGKERHTL	SGF29	191	Q96ES7
EEEEEEEEENPVHKI	WDR70	156	Q9NW82
LKEEEEDGQEGSIHN	WDHD1	396	O75717
EEEEEKEPGEVGTHN	SPARCL1	201	Q14515
HKVRDQEEEEEEEAA	ZNF592	1176	Q92610
EEQSEKDHNDAEEEP	ZBTB41	321	Q5SVQ8
SHLAEEEGEDKEDSQ	DPF2	231	Q92785
EIHIDTADKEIEQGD	SNX19	446	Q92543
GLQRHSDEEEEDDEE	ZBTB47	271	Q9UFB7
DDEEEEQEVDVEGHK	SKOR2	736	Q2VWA4
HDLDLVKEQLEEEQG	MYH16	501	Q9H6N6
SDSDDEDKLHIVEEE	ZEB1	31	P37275
DDVIREEEHEEKNSG	ZCCHC7	46	Q8N3Z6
EEEAQEEAAEVHEEV	TNNT3	16	P45378
EEAAEVHEEVHEPEE	TNNT3	21	P45378
KSHVTEEEEEEEEEE	SNAPC5	81	O75971
DIEALKEEDEDDDHG	USP34	616	Q70CQ2
SETDEEDKLHIAEDD	ZEB2	36	O60315
RNDHDDDEDEEVISK	GTF3C1	341	Q12789
EEQLLGEHIKEEKEE	SEC31A	536	O94979
EEEEETHKIGSLAEN	TREML1	126	Q86YW5
KENIKEHLLDDEEED	WDR7	751	Q9Y4E6
KVQEEEHDLVDDDIT	WDR7	1086	Q9Y4E6
EQEEHVKGEDEDILG	PSD3	416	Q9NYI0
LKAAEIDEEHVEDDG	TSHZ1	21	Q6ZSZ6
LAEDHTIIVEEDKEE	ZFHX3	1481	Q15911
QKGILSHEEEDEEEE	MYT1	251	Q01538